Literature DB >> 1587431

Measurements of iron status in patients with chronic hepatitis.

A M Di Bisceglie1, C A Axiotis, J H Hoofnagle, B R Bacon.   

Abstract

Eighty patients with chronic viral hepatitis were screened for evidence of iron overload. Elevated serum iron values were noted in 36% of cases; serum ferritin values were above normal in 30% of men and 8% of women. Twenty-eight additional patients with chronic hepatitis for whom liver tissue was available for determination of iron content were evaluated to study the significance of iron overload in association with chronic hepatitis. Although 46% had elevated serum iron, ferritin, or transferrin-saturation levels, the hepatic iron concentration was elevated in only four cases, and the hepatic iron index was in the range for hereditary hemochromatosis (greater than 2.0) in only two of these. Serum aspartate aminotransferase activities correlated with serum ferritin levels in these patients, suggesting that ferritin and iron levels were increased in serum because of their release from hepatocellular stores associated with necrosis. Thus, in patients with chronic hepatitis in whom hereditary hemochromatosis is suspected, a liver biopsy should be performed with quantitation of hepatic iron and calculation of the hepatic iron index to confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587431     DOI: 10.1016/0016-5085(92)90339-z

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  71 in total

1.  Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.

Authors:  C Chapoutot; M Esslimani; Z Joomaye; J Ramos; P Perney; C Laurent; P Fabbro-Peray; D Larrey; J Domergue; F Blanc
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

2.  Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Authors:  Naoki Fujita; Mamoru Nakanishi; Jun Mukai; Yuuji Naito; Takafumi Ichida; Masahiko Kaito; Toshikazu Yoshikawa; Yoshiyuki Takei
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

3.  Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C.

Authors:  Masahiko Kaito; Motoh Iwasa; Yoshinao Kobayashi; Naoki Fujita; Hideaki Tanaka; Esteban C Gabazza; Yukihiko Adachi; Yuji Kojima; Naoki Nakagawa; Shozo Watanabe
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

4.  Molecular mechanism of iron metabolism and overload in chronic hepatitis C.

Authors:  Masahiko Kaito
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

5.  Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?

Authors:  Deniz Güney Duman; Cigdem Celikel; Davut Tüney; Nese Imeryüz; Erol Avsar; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 6.  The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Authors:  Leslie Price; Kris V Kowdley
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

7.  Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.

Authors:  Wei-Hong Hou; Lisa Rossi; Ying Shan; Jian-Yu Zheng; Richard-W Lambrecht; Herbert-L Bonkovsky
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

8.  Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience.

Authors:  Paul R Yenson; Eric M Yoshida; Charles H Li; Henry V Chung; Peter Wk Tsang
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

9.  Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Christine E McLaren; Victor R Gordeuk; Wen-Pin Chen; James C Barton; Ronald T Acton; Mark Speechley; Oswaldo Castro; Paul C Adams; Beverly M Snively; Emily L Harris; David M Reboussin; Geoffrey J McLachlan; Richard Bean
Journal:  Transl Res       Date:  2007-11-09       Impact factor: 7.012

10.  Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Authors:  Sven G Gehrke; Wolfgang Stremmel; Inge Mathes; Hans-Dieter Riedel; Karin Bents; Birgit Kallinowski
Journal:  J Mol Med (Berl)       Date:  2003-10-14       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.